Literature DB >> 19211565

Activation of protein kinase C{eta} by type I interferons.

Amanda J Redig1, Antonella Sassano, Beata Majchrzak-Kita, Efstratios Katsoulidis, Hui Liu, Jessica K Altman, Eleanor N Fish, Amittha Wickrema, Leonidas C Platanias.   

Abstract

Type I interferons (IFNs) are cytokines with diverse biological properties, including antiviral, growth inhibitory, and immunomodulatory effects. Although several signaling pathways are activated during engagement of the type I IFN receptor and participate in the induction of IFN responses, the mechanisms of generation of specific signals for distinct biological effects remain to be elucidated. We provide evidence that a novel member of the protein kinase C (PKC) family of proteins is rapidly phosphorylated and activated during engagement of the type I IFN receptor. In contrast to other members of the PKC family that are also regulated by IFN receptors, PKCeta does not regulate IFN-inducible transcription of interferon-stimulated genes or generation of antiviral responses. However, its function promotes cell cycle arrest and is essential for the generation of the suppressive effects of IFNalpha on normal and leukemic human myeloid (colony-forming unit-granulocyte macrophage) bone marrow progenitors. Altogether, our studies establish PKCeta as a unique element in IFN signaling that plays a key and essential role in the generation of the regulatory effects of type I IFNs on normal and leukemic hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211565      PMCID: PMC2667717          DOI: 10.1074/jbc.M807254200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1alpha transcriptional activation.

Authors:  Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2004-04-13       Impact factor: 5.157

Review 2.  Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.

Authors:  Montserrat Barragán; Clara Campàs; Beatriz Bellosillo; Joan Gil
Journal:  Leuk Lymphoma       Date:  2003-11

3.  Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells.

Authors:  Simrit Parmar; Efstratios Katsoulidis; Amit Verma; Yongzhong Li; Antonella Sassano; Lakhvir Lal; Beata Majchrzak; Farhad Ravandi; Martin S Tallman; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2004-03-31       Impact factor: 5.157

4.  Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway.

Authors:  Lena Thyrell; Linn Hjortsberg; Velmurugesan Arulampalam; Theocharis Panaretakis; Sabine Uhles; Markus Dagnell; Boris Zhivotovsky; Ingo Leibiger; Dan Grandér; Katja Pokrovskaja
Journal:  J Biol Chem       Date:  2004-03-31       Impact factor: 5.157

Review 5.  The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.

Authors:  A-R Hanauske; Karen Sundell; Michael Lahn
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

6.  Engagement of protein kinase C-theta in interferon signaling in T-cells.

Authors:  Kishore K Srivastava; Sandeep Batra; Antonella Sassano; Yongzhong Li; Beata Majchrzak; Hiroaki Kiyokawa; Amnon Altman; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2004-05-18       Impact factor: 5.157

7.  Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.

Authors:  Shahab Uddin; Jeong Ah-Kang; Jodie Ulaszek; Dolores Mahmud; Amittha Wickrema
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

Review 8.  Interferons: mechanisms of action and clinical applications.

Authors:  Simrit Parmar; Leonidas C Platanias
Journal:  Curr Opin Oncol       Date:  2003-11       Impact factor: 3.645

9.  Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.

Authors:  E van 't Hull; H Schellekens; B Löwenberg; M J de Vries
Journal:  Cancer Res       Date:  1978-04       Impact factor: 12.701

Review 10.  Protein kinase C isozymes as potential targets for anticancer therapy.

Authors:  Johann Hofmann
Journal:  Curr Cancer Drug Targets       Date:  2004-03       Impact factor: 3.428

View more
  13 in total

1.  Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses.

Authors:  Barbara Kroczynska; Robert L Rafidi; Beata Majchrzak-Kita; Ewa M Kosciuczuk; Gavin T Blyth; Jacek Jemielity; Zofia Warminska; Diana Saleiro; Swarna Mehrotra; Ahmet Dirim Arslan; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

2.  Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.

Authors:  Swarna Mehrotra; Bhumika Sharma; Sonali Joshi; Barbara Kroczynska; Beata Majchrzak; Brady L Stein; Brandon McMahon; Jessica K Altman; Jonathan D Licht; Darren P Baker; Elizabeth A Eklund; Amittha Wickrema; Amit Verma; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

3.  Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses.

Authors:  Surinder Kaur; Barbara Kroczynska; Bhumika Sharma; Antonella Sassano; Ahmet Dirim Arslan; Beata Majchrzak-Kita; Brady L Stein; Brandon McMahon; Jessica K Altman; Bing Su; Raffaele A Calogero; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

4.  Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesis.

Authors:  Bhumika Sharma; Jessica K Altman; Dennis J Goussetis; Amit K Verma; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

5.  Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.

Authors:  Efstratios Katsoulidis; Evangelos Mavrommatis; Jennifer Woodard; Mario A Shields; Antonella Sassano; Nathalie Carayol; Konrad T Sawicki; Hidayatullah G Munshi; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

6.  Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.

Authors:  Kazuchika Nishitsuji; Takashi Hosono; Toshiyuki Nakamura; Guojun Bu; Makoto Michikawa
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

Review 7.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

8.  Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.

Authors:  Barbara Kroczynska; Bhumika Sharma; Elizabeth A Eklund; Eleanor N Fish; Leonidas C Platanias
Journal:  Mol Cell Biol       Date:  2012-05-14       Impact factor: 4.272

Review 9.  Yin and Yang: The dual effects of interferons on hematopoiesis.

Authors:  Yasmin Demerdash; Bailee Kain; Marieke A G Essers; Katherine Y King
Journal:  Exp Hematol       Date:  2021-02-08       Impact factor: 3.084

10.  Protein kinase C activation mediates interferon-β-induced neuronal excitability changes in neocortical pyramidal neurons.

Authors:  Olivia Reetz; Konstantin Stadler; Ulf Strauss
Journal:  J Neuroinflammation       Date:  2014-10-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.